Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy

Brain

Volumn 128, Issue 6, 2005, Pages 1259-1266

  Cordato, N J ^a,b   Duggins, A J ^b   Halliday, G M ^c   Morris, J G L ^b   Pantelis, C ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Parkinson's disease; Progressive supranuclear palsy; Regional brain atrophy; Voxel based morphometry

Indexed keywords

AGED; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; CINGULATE GYRUS; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; WHITE MATTER;

EID: 20444464006     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh508     Document Type: Article

References (42)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P, Nielsen H. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387-92.
2. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001; 56: 730-6.
3. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol 2002; 12: 169-77.
4. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000; 11: 805-21.
5. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 246-9.
6. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791-800.
7. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000; 47: 718-28.
8. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002; 125: 789-800.
9. Cummings JL. Fronto-subcortical circuits in human behaviour. Arch Neurol 1993; 50: 873-80.
10. Cunnington R, Windischberger C, Deecke L, Moser E. The preparation and readiness for voluntary movement: a high-field event-related fMRI study of the Bereitschafts-BOLD response. Neuroimage 2003; 20: 404-12.
11. Da Cunha C, Angelucci ME, Canteras NS, Wonnacott S, Takahashi RN. The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cell Mol Neurobiol 2002; 22: 227-37.
12. Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y. Age-induced cognitive disturbances in Parkinson's disease. Neurology 1990; 40: 38-41.
13. Fahn S, Elton RL, members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: MacMillan Healthcare Information; 1987. p. 153-163, 293-304.
14. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-9.
15. Ghez C, Thach WT. The cerebellum. In: Kandel ER, Schwartz JH, Jessell TM, editors. The principles of neural science. New York: McGraw-Hill; 2000. p. 832-52.
16. Good CD, Johnsrude IS, Ashburner J, Henson RNA, Friston KJ, Frackowiak RSJ. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21-36.
17. Groschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004; 21: 714-24.
18. Hauw J, Daniel S, Dickson D, Horoupian D, Jellinger K, Lantos P, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-9.
19. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000; 123: 1410-21.
20. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-42.
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
22. Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 1997; 24: 29-36.
23. Kusunoki M, Colby CL, Duhamel J-R, Goldberg ME. The role of the lateral interparietal area in the control of visuospatial attention. In: Sakata H, Mikami A, Fuster JM, editors. The association cortex-structure and function. New York: Harwood Academic Publishers; 1997. p. 191-205.
24. Litvan I. Recent advances in atypical parkinsonian disorders. Curr Opin Neurol 1999; 12: 441-6.
25. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996a; 47: 1-9.
26. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996b; 47: 1184-9.
27. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-24.
28. Mura A, Feldon J. Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov Disord 2003; 18: 860-71.
29. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001; 124: 1438-49.
30. Park LC, Albers DS, Xu H, Lindsay JG, Seal MF, Gibson GE. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J Neurosci Res 2001; 66: 1028-34.
31. Percheron G, Francois C, Yelnik J, Fenelon G, Talbi B. The basal ganglia related system of primates: definition, description and informational analysis. New York: Plenum Press; 1994.
32. Piao YS, Hayashi S, Wakabayashi K, Kakita A, Aida I, Yamada M, et al. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol (Berl) 2002; 103: 469-74.
33. Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 2002; 58: 198-208.
34. Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999; 45: 65-74.
35. Stancak A, Cohen ER, Seidler RD, Duong TQ, Kim SG. The size of corpus callosum correlates with functional activation of medial motor cortical areas in bimanual and unimanual movements. Cereb Cortex 2003; 13: 475-85.
36. Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003; 60: 1766-9.
37. Tzschentke TM. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 2001; 63: 241-320.
38. Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet A-M, Gaymard B, et al. Eye movements in Parkinsonian syndromes. Ann Neurol 1994; 34: 420-6.
39. Wright MJ, Geffen GM, Geffen LB. Event-related potentials associated with covert orientation of visual attention in Parkinson's disease. Neuropsychologia 1993; 31: 1283-97.
40. Yamaguchi S, Kobayashi S. Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention. J Neurosci 1998; 18: 1869-78.
41. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, et al. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol 1997; 41: 606-14.
42. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 623-9.